Morphic Holding Inc (MORF)
33.46
+2.00
(+6.36%)
USD |
NASDAQ |
Jun 25, 16:00
33.46
0.00 (0.00%)
After-Hours: 20:00
Morphic Cash from Financing (Quarterly): 0.911M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.911M |
| December 31, 2023 | 0.034M |
| September 30, 2023 | 19.29M |
| June 30, 2023 | 331.63M |
| March 31, 2023 | 102.48M |
| December 31, 2022 | 0.575M |
| September 30, 2022 | 1.181M |
| June 30, 2022 | 40.88M |
| March 31, 2022 | 2.63M |
| December 31, 2021 | 2.674M |
| September 30, 2021 | 21.58M |
| June 30, 2021 | 1.481M |
| March 31, 2021 | 240.58M |
| Date | Value |
|---|---|
| December 31, 2020 | 29.68M |
| September 30, 2020 | 7.279M |
| June 30, 2020 | 0.535M |
| March 31, 2020 | 0.803M |
| December 31, 2019 | 0.028M |
| September 30, 2019 | 95.10M |
| June 30, 2019 | -1.833M |
| March 31, 2019 | 0.00 |
| December 31, 2018 | -0.405M |
| September 30, 2018 | 90.04M |
| June 30, 2018 | -0.086M |
| March 31, 2018 | -0.083M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-1.833M
Minimum
Jun 2019
331.63M
Maximum
Jun 2023
44.88M
Average
2.652M
Median
Cash from Financing (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 28.91M |
| Cytokinetics Inc | 103.79M |
| Amicus Therapeutics Inc | -13.31M |
| Insmed Inc | 3.022M |
| Madrigal Pharmaceuticals Inc | 573.71M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -46.39M |
| Cash from Investing (Quarterly) | 31.37M |
| Free Cash Flow | -128.61M |
| Free Cash Flow Per Share (Quarterly) | -0.9411 |
| Free Cash Flow Yield | -8.27% |